Abstract
Nicotinic acetylcholine receptors (AChRs) are valuable therapeutic targets. To exploit them fully requires rapid assays for the evaluation of potentially therapeutic ligands and improved understanding of the interaction of such ligands with their receptor binding sites.
Original language | English |
---|---|
Pages (from-to) | 920-931 |
Number of pages | 11 |
Journal | British Journal of Pharmacology |
Volume | 150 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2007 |
Keywords
- nicotinic
- vecuronium
- receptor
- evolution
- proline
- phenylalanine
- serine
- binding